Big Health Raises $75M in Series C Funding

Big Health, a digital therapeutics company dedicated to mental health, raised $75 million in Series C funding. The round was led by new investor SoftBank Vision Fund 2, with participation from ArrowMark Partners and existing investors Octopus Ventures, Gilde Healthcare, Kaiser Permanente Ventures (KPV), and Morningside Ventures. Big Health intends to use the funds to further accelerate commercial growth and product strategy, and to launch six new digital therapeutics by 2024. 

Big Health Secures $75 Million in Series C Funding Led by SoftBank Vision Fund 2

Big Health is a digital therapeutics company that expands access to care, including behavioral medicine, integrating across the care pathway, from member engagement to billing via pharmacy benefit managers. Through clinical evaluation, Sleepio and Daylight – the company’s first two digital therapeutics for insomnia and anxiety, respectively – are proven to provide effective non-drug alternatives for the most common mental health conditions without requiring a prescription or intervention from coaches or clinicians. To ease adoption for payers and patients alike, the company gives the ability to bill through the PBM, enabling employers and health plans to add Big Health to their formulary and pay for their use via a drug claim, which is the same way they pay for medications.

Big Health is a digital therapeutics company dedicated to mental health.

4 years ago

Big Health Secures $75 Million in Series C Funding Led by SoftBank Vision Fund 2

ProblemHealthcare

Solution

Covered on